Cooperative Agreement 90PD0316

This $1,016,264 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to develop and evaluate digital screening and brief intervention (e-SBI) approaches for addressing perinatal substance use in home visiting programs. The project, led by the non-profit organization Partnership To End Addiction, will pilot test three e-SBI delivery strategies - a single session, a session plus booster, and post-session text...

This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $193,550 to Boston Medical Center Corporation to develop a peer breastfeeding support intervention for mothers with opioid use disorder (OUD). The key objectives are to: 1) Engage mothers with OUD to identify breastfeeding facilitators and understand the potential influence of breastfeeding on OUD recovery; 2) Facilitate focus groups with OUD...

This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports the development and evaluation of a mobile health (mHealth) intervention to provide psychosocial and self-management support for postpartum individuals recovering from opioid use disorder (OUD). The $174,378 award will fund the iterative development of an Acceptance and Commitment Therapy (ACT)-based mHealth intervention, incorporating a...

This $945,397 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to adapt and evaluate a Collaborative Care Model (CCM) for treating pregnant and postpartum persons with opioid use disorder (OUD) in low-resource obstetric settings. The key objectives are to: 1) adapt an existing CCM for rural and low-resource obstetric sites; 2) create a common data model to harmonize data across study sites; 3)...

This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $193,752 to Boston Medical Center Corporation to test the effectiveness of a video-coaching intervention called THRIVE in promoting positive parenting behaviors among mothers with opioid use disorder (OUD) and their preschool-aged children. The 5-year award, beginning on April 15, 2025, aims to address the urgent need to make...

This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), will leverage artificial intelligence methods and electronic health records to conduct pharmacoepidemiologic studies on adverse pediatric outcomes associated with maternal substance use during pregnancy and pediatric drug exposures. The goal is to develop a stakeholder-informed real-time pediatric...

This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $445,000 to The Children's Hospital Corporation (doing business as Boston Children's Hospital) to develop and pilot test a telehealth-based cannabis use intervention for young adults aged 18-26 years. The project, titled "Developing a Telehealth + mHealth Cannabis Use Intervention for Young Adults (MOMENT-V)", aims to evaluate the...

This $382,226 Project Grant from the Department of Health and Human Services' National Institutes of Health National Institute of Child Health and Human Development supports the development of a platform for uncovering new drug safety information through analysis of linked electronic health records. Vanderbilt University Medical Center will analyze 48,434 linked maternal and neonatal EHRs to apply a medication-wide association study and discover associations between maternal drug exposures and...

The National Institute on Drug Abuse (NIDA) awarded The Washington University a 3-year, $2,337,729 Project Grant under the Drug Abuse and Addiction Research Programs (CFDA 93.279) to study the impact of prenatal opioid exposure on placental and fetal brain development. The project, titled "The Opioid in Pregnancy: Imaging of Oxygenation, Inflammation, and Development in Brain & Placenta" (OPIOID BPP), aims to define the longitudinal effects of prenatal opioid exposure on...

This Project Grant award, with a total funding of $180,059, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The award supports a study titled "Optimizing Developmental Outcomes in Early Childhood After Neonatal Opioid Withdrawal Syndrome" at the Research Institute at Nationwide Children's Hospital (RINCH), a prominent non-profit research organization. The key objectives of this study are to: 1) engage with...